USANA Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	63.79	69.35	116.51	124.66	100.53	126.22	62.54	100.04	94.67	76.64	Upgrade
Depreciation & Amortization	20.4	21.41	22.19	22.51	23.01	16.84	16.11	13.48	9.98	8.81	Upgrade
Share-Based Compensation	14.6	13.33	14.3	14.39	15.54	14.96	15.48	16.54	11.08	9.68	Upgrade
Other Operating Activities	-28.14	-0.19	-31.77	-1.17	-12.34	-5.9	29.65	6.83	-4.27	10.06	Upgrade
Operating Cash Flow	70.64	103.9	121.23	160.4	126.73	152.12	123.77	136.89	111.47	105.19	Upgrade
Operating Cash Flow Growth	-32.01%	-14.29%	-24.42%	26.57%	-16.69%	22.90%	-9.58%	22.81%	5.97%	6.36%	Upgrade
Capital Expenditures	-14.48	-10.39	-12.75	-15.09	-16.55	-11.05	-13.2	-32.69	-23.54	-20.41	Upgrade
Acquisitions	0	-6.53	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	2.5	4.56	-1.44	-18.87	64.05	-57.95	0.3	0.8	-1.58	4.15	Upgrade
Investing Cash Flow	-11.98	-12.37	-14.19	-33.96	47.49	-69	-12.9	-31.88	-25.12	-16.27	Upgrade
Share Issuance / Repurchase	-11.6	-25.38	-177.84	-57.03	-150	-105.38	-50	-64.61	-61.18	-127.85	Upgrade
Debt Issued / Paid	0.79	0	0	-0.05	-0.07	0	0	0	0	0	Upgrade
Other Financing Activities	-3.43	-4.71	-3.58	-2.37	-1.99	0.1	-0.32	-0.25	12.02	14.83	Upgrade
Financing Cash Flow	-14.24	-30.09	-181.41	-59.44	-152.05	-105.28	-50.32	-64.86	-49.16	-113.02	Upgrade
Exchange Rate Effect	-2.5	-13.78	2.09	11.25	-1.72	-11.14	11.03	-7.93	-5.1	-2.12	Upgrade
Net Cash Flow	41.93	47.67	-72.28	78.25	20.45	-33.3	71.58	32.22	32.08	-26.22	Upgrade
Free Cash Flow	56.16	93.51	108.48	145.31	110.18	141.07	110.58	104.2	87.92	84.77	Upgrade
Free Cash Flow Growth	-39.94%	-13.80%	-25.35%	31.89%	-21.89%	27.57%	6.11%	18.52%	3.71%	-6.73%	Upgrade
Free Cash Flow Margin	6.10%	9.36%	9.14%	12.81%	10.39%	11.86%	10.56%	10.36%	9.57%	10.72%	Upgrade
Free Cash Flow Per Share	2.92	4.86	5.38	6.87	4.87	5.85	4.54	4.31	3.45	3.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).